DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction

MANUFACTURER: Daiichi Sankyo Company Limited

USAGE: Intravenous

MEDICINE APPROVED BY:

Pharmaceuticals and Medical Devices Agency (PMDA)

Edaravone is a medication used to treat amyotrophic lateral sclerosis (ALS), administered intravenously in a hospital setting. It reduces oxidative stress, which damages nerve cells.